Novartis (NVSEF) Stock Price, News & Analysis
Company Description
Novartis (OTC Link: NVSEF) is a publicly traded company.
NVSEF stock has gained 23.5% over the past year. Shares last traded at $153.65.
On a trailing twelve-month basis, Novartis reported net income of $14.0B and diluted earnings per share of $7.15.
This page provides a comprehensive overview of NVSEF stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novartis (NVSEF) stock last traded at $153.65, down 3.17% from the previous close. Over the past 12 months, the stock has gained 23.5%.
NVSEF Rankings
Latest News
SEC Filings
Novartis has filed 5 recent SEC filings, including 3 Form 144, 2 Form 6-K. The most recent filing was submitted on June 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NVSEF SEC filings →
Financial Highlights
net income was $14.0B. Diluted earnings per share stood at $7.15. The company generated $19.1B in operating cash flow. With a current ratio of 1.12, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Novartis (NVSEF) currently stands at 1.5 million shares, up 28.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 54.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Novartis (NVSEF) currently stands at 4.9 days, down 93% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 92% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 4.4 to 1000.0 days.